Associate Director, Chemical Development

About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs.

At Acadia, we’re here to be their difference. Please note that this position can be based in Princeton, NJ OR San Diego, CA. Acadia's hybrid model requires this role to work in our office an average of 3 days per week.

Position Summary: Responsible for the chemical process development, implementation and management of robust, cost effective, and safe processes for the manufacture of APIs from the research stage, through clinical development and marketing approval. Will be responsible for the technical development, support, innovative solutions and commercialization of drug substances using an external network of providers. This position is integral to the advancement of Acadia's growing portfolio of drug candidates, and will provide technical oversight, expertise and guidance of externalized drug substance development related activities.

Responsibilities

D. degree in Synthetic Organic Chemistry or other related scientific discipline. A minimum of 8-9 years of relevant progressive experience in API development and manufacturing in the pharmaceutical/biotechnology industry with a minimum of 8 years in a scientific role.

An equivalent combination of relevant education and applicable job experience may be considered Leadership experience in managing diverse project activities with contract CDMO facilities at different global locations Experience with global pharmaceutical/chemical development and manufacturing operations for development-stage small molecules, including upstream/downstream process development. g.